Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3

被引:44
作者
Yamaki, T
Endoh, K
Miyahara, M
Nagamine, I
Huong, NTT
Sakurai, H
Pokorny, J
Yano, T
机构
[1] Natl Inst Hlth & Nutr, Dept Food Sci Res Hlth, Shinjuku Ku, Tokyo 1628636, Japan
[2] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2528510, Japan
[3] Fac Food & Biochem Technol, Inst Chem Technol, CZ-16628 Prague 6, Czech Republic
关键词
PGE2; Src; EP3; lung adnocarcinoma;
D O I
10.1016/j.canlet.2004.04.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accumulating evidence suggests that overproduction of prostaglandin (PG) E2 attributable to induction of cyclooxygenase-2 plays an important role in the development of lung adenocarcinoma. Recently, we have reported that a PGE2 receptor, EP3 is involved in appearance of malignant phenotype of a lung adenocarcinoma cell (A549 cell). In line with our previous study, here we investigated if Src signaling could be involved in PGE2-stimulated growth of A549 cells via EP3. PGE2-dependent cell growth in A549 cell positively related to the activation of Src. A specific antagonist against EP3 abrogated the cell growth and Src activation in the cells stimulated with PGE2. Also, the inhibition of Src activity suppressed its downstream signaling related to cell growth as well as the cell growth in the cells treated with PGE2. These results indicate that PGE2-dependent activation of Src signaling via EP3 plays an important role in growth of A549 cells. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 27 条
[1]   Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth [J].
Amano, H ;
Hayashi, J ;
Endo, H ;
Kitasato, H ;
Yamashina, S ;
Maruyama, T ;
Kobayashi, M ;
Satoh, K ;
Narita, M ;
Sugimoto, Y ;
Murata, T ;
Yoshimura, H ;
Narumiya, S ;
Majima, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :221-232
[2]  
BOS JL, 1989, CANCER RES, V49, P4682
[3]   Prostaglandin E receptors and the kidney [J].
Breyer, MD ;
Breyer, RM .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (01) :F12-F23
[4]  
Buettner R, 2002, CLIN CANCER RES, V8, P945
[5]   Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer [J].
Campa, D ;
Zienolddiny, S ;
Maggini, V ;
Skaug, V ;
Haugen, A ;
Canzian, F .
CARCINOGENESIS, 2004, 25 (02) :229-235
[6]   Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression [J].
Chang, SH ;
Liu, CH ;
Conway, R ;
Han, DK ;
Nithipatikom, K ;
Trifan, OC ;
Lane, TF ;
Hla, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :591-596
[7]   BCL-2 FAMILY: Regulators of cell death [J].
Chao, DT ;
Korsmeyer, SJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :395-419
[8]  
Ciardiello F, 2001, CLIN CANCER RES, V7, P2958
[9]  
COLEMAN RA, 1994, PHARMACOL REV, V46, P205
[10]   Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3 [J].
Corre, I ;
Baumann, H ;
Hermouet, S .
ONCOGENE, 1999, 18 (46) :6335-6342